DEBRA MCKINNEY: Open Payments
NPI 1639673486 · AKRON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 58 payments from 13 companies in 2025. Trend: 2023 $1,111 · 2024 $1,318 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $335 |
| Insulet Corporation | 9 | $240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $164 |
| Tandem Diabetes Care, Inc. | 1 | $119 |
| AstraZeneca Pharmaceuticals LP | 1 | $101 |
| Lilly USA, LLC | 6 | $98 |
| Corcept Therapeutics | 4 | $83 |
| Medtronic, Inc. | 2 | $48 |
| BETA BIONICS, INC. | 2 | $32 |
| Amgen Inc. | 2 | $31 |
Products named: Ozempic, Omnipod, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, WAINUA, Korlym, MOUNJARO, Rybelsus.
Industry payments across OH — which companies pay providers there.
